A pending FDA guidance on new dietary ingredients underscores why the agency’s GRAS overhaul could determine which natural products reach market—and which are eliminated. Action Alert! Listen to the audio version of this article: THE TOPLINE The Food and Drug Administration (FDA) is scheduled to release another set of guidance documents that will control how […]
ANH founder Rob Verkerk explains why outdated food-drug definitions restrict consumer access to natural health options—and how a more proportionate system could better protect both choice and safety. Listen to the audio version of this article: The following is a transcript of an interview with Rob Verkerk, PhD, and ANH-USA’s Editorial Director, Michael Ames-Sikora. Today […]
The federal government is preparing to outlaw many full-spectrum hemp products while withholding basic information businesses need to understand the new law. If you care about your access to CBD and other non-intoxicating cannabinoids, please sign our Action Alert now! Listen to the audio version of this article: THE TOPLINE The Food and Drug Administration […]
A new HHS report on questionable medical billing is part of a broader—yet at times inconsistent—effort to challenge pharmaceutical influence, improve nutrition, lower healthcare costs, and shift federal policy toward prevention. Listen to the audio version of this article: THE TOPLINE A new report commissioned by the Department of Health and Human Services (DHHS) examines […]
After more than three decades without a prescription drug, one week on allopurinol triggered a cascade of painful and potentially long-term symptoms—and exposed how far healthcare still has to go in recognizing informed consent, individual susceptibility and the value of integrative care
As animal health shifts toward pharma and biotech-driven interventions, basic determinants like nutrition, exercise and stress are being sidelined despite their immense impact on both health-span and lifespan. Original article by Melissa Smith, Outreach & Communications Officer, ANH International Abbreviated version below edited by Mike Ames-Sikora, Senior Editor, ANH-USA. Read the full version at ANH International […]
The FDA under the leadership of Acting Commissioner Kyle Diamantas is poised to eliminate access to compounded natural desiccated thyroid. For patients who depend on individualized thyroid treatment, the consequences could be devastating. Action Alert! Listen to the audio version of this article: THE TOPLINE The Food and Drug Administration has issued a new statement […]
Vaccine choice only works when government recommendations, evidence, and potential conflicts are communicated clearly and consistently with sufficient transparency. Recent and past comments by HHS Secretary Kennedy don’t meet these standards and likely exacerbate public confusion and polarization. Listen to the audio version of this article: THE TOPLINE During a contentious CNN interview, HHS Secretary […]
FDA’s proposed GRAS reform could deliver long-overdue transparency to what’s in America’s food supply—but unless the agency modernizes its approach to natural ingredients, consumers may pay the price in reduced innovation, choice, and access. Action Alert! Listen to the audio version of this article: THE TOPLINE With GRAS reform being a headline priority for Secretary […]
A sweeping new Executive Order could significantly reshape childhood vaccine policy by prioritizing individualized recommendations, parental choice, flexible scheduling, and new scrutiny of vaccine safety. Listen to the audio version of this article: THE TOPLINE President Trump’s August 10 executive order, “Delivering Gold Standard Childhood Vaccine Recommendations for Americans,” marks a significant change in federal […]